Back to search
FDAFDA · Food and drugs·Recall number Z-0634-2024

External Drainage System Collection Bag, REF: NT821732C, STERILEEO, Rx only

Published January 10, 2024 · Recall initiated: November 28, 2023

Summary

FDA records medical device Class II recall Z-0634-2024, published January 10, 2024 and initiated November 28, 2023. Recalling firm: Natus Medical Incorporated; Status: Ongoing; Reported quantity: 2,686 units; Lot: UDI: 00382830050562/ Lot #: 1FX0004951660 1FX0004951658 1FX0004951659 1FX0005040450 1FX0005040451 1FX0005040452 1FX0005040453 1FX0005040454 1FX0005040457 1FX0005040456 1FX0005079696 1FX0005126475 1FX0005126474 1FX0005040455. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Sterility assurance cannot be guaranteed for external drainage systems due to incomplete bioburden testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Natus Medical Incorporated
Distributor
US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, FL, GA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV.
Lot
UDI: 00382830050562/ Lot #: 1FX0004951660 1FX0004951658 1FX0004951659 1FX0005040450 1FX0005040451 1FX0005040452 1FX0005040453 1FX0005040454 1FX0005040457 1FX0005040456 1FX0005079696 1FX0005126475 1FX0005126474 1FX0005040455
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was External Drainage System Collection Bag, REF: NT821732C, STERILEEO, Rx only recalled?

Yes. FDA published recall Z-0634-2024 on January 10, 2024. Reported hazard: Sterility assurance cannot be guaranteed for external drainage systems due to incomplete bioburden testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter